{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_52760"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_52760","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"Identification and characterization of intracellular Brucella inhibitors and host genes that support Brucella infection","abstract":"Thesis (Ph.D.)--Michigan State University. Microbiology and Molecular Genetics - Doctor of Philosophy, 2025","abstract_html":"Thesis (Ph.D.)--Michigan State University. Microbiology and Molecular Genetics - Doctor of Philosophy, 2025","abstract_has_math":false,"creators":["Kim, Thomas"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Crosson, Sean"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2025,"date_issued":"2025","date_published":"2025","updated_at":"2026-11-18T18:59:28Z","subjects":["Microbiology"],"languages":["eng"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52760","local:Kim_grad.msu_0128D_21743"],"render_values":[{"text":"etd:52760","href":null,"code":true},{"text":"local:Kim_grad.msu_0128D_21743","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/yx7g-0d25","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/yx7g-0d25","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_52760","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Crosson, Sean"]},{"key":"dc:creator","label":"Author","values":["Kim, Thomas"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2025"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["text","Electronic dissertations"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Microbiology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52760","local:Kim_grad.msu_0128D_21743","https://doi.org/doi:10.25335/yx7g-0d25"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (Ph.D.)--Michigan State University. Microbiology and Molecular Genetics - Doctor of Philosophy, 2025","Brucellosis is a widespread zoonosis caused by intracellular bacterial pathogens of the genus, Brucella. While it is well established that nearly all Brucella species infect and replicate within mammalian phagocytes, our understanding of the specific host factors and host-cellular processes that facilitate Brucella infection into host cells remain incomplete. To address this gap, we conducted both pharmacologic and genetic screens to identify pathways and genes that are critical for supporting Brucella infection in macrophages, yielding new insights into pathogen biology. Through a luminescence-based small molecule screen, I identified clinically approved dihydropyridines that reduced the fitness of the intracellular pathogen Brucella ovis within mammalian phagocytes. I initially hypothesized a host-directed mechanism of action for dihydropyridine treatment however, dose-response assays in axenic medium revealed that these drugs can directly inhibit B. ovis growth at concentrations just above that used in the screen. To explore the genetic basis of B. ovis dihydropyridine sensitivity, we selected for mutants capable of growing in the presence of the dihydropyridine cilnidipine. Cilnidipine-resistant mutants carried single-base deletions in the bepE transporter pseudogene that restored an open reading frame, enabling expression of a functional RND-family transporter. Reversion mutations that restored the bepE open reading frame increased B. ovis resistance not only to dihydropyridines but also to a broad range of cell envelope-disrupting agents. Conversely, deleting bepE in Brucella abortus, a closely related zoonotic species that retains an intact version of the gene, increased its sensitivity to envelope disruptors in vitro and to cilnidipine in the intracellular niche. As a complementary approach to small molecule screens, genetic screens can also reveal potential pharmacologic targets for host-directed therapy and inform novel pathogen biology. To this end, we conducted a genome-wide forward genetic CRISPR-Cas9 screen in THP-1 human macrophage-like cells to identify host genes that support B. ovis and B. abortus early infection. This screen revealed pan-infection host factors, and novel host cellular pathways that support Brucella infection, including the mechanistic target of rapamycin (mTOR) signaling pathway, with key genes such as LAMTOR2 and AKT1 emerging as notable hits. We validated the involvement of several candidate genes by generating targeted knockouts in THP-1 cells and through pharmacological inhibition, confirming their roles in promoting Brucella infection. These results illuminate a diverse set of host factors and cellular pathways that support infection, offering new insights into Brucella infection biology and identifying potential targets for future therapeutic intervention.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf","1 online resource (128 p.) : ill."]},{"key":"dc:title","label":"Title","values":["Identification and characterization of intracellular Brucella inhibitors and host genes that support Brucella infection"]}]}],"canonical_facts":{"dc:contributor":["Crosson, Sean"],"dc:creator":["Kim, Thomas"],"dc:date":["2025"],"dc:description":["Thesis (Ph.D.)--Michigan State University. Microbiology and Molecular Genetics - Doctor of Philosophy, 2025","Brucellosis is a widespread zoonosis caused by intracellular bacterial pathogens of the genus, Brucella. While it is well established that nearly all Brucella species infect and replicate within mammalian phagocytes, our understanding of the specific host factors and host-cellular processes that facilitate Brucella infection into host cells remain incomplete. To address this gap, we conducted both pharmacologic and genetic screens to identify pathways and genes that are critical for supporting Brucella infection in macrophages, yielding new insights into pathogen biology. Through a luminescence-based small molecule screen, I identified clinically approved dihydropyridines that reduced the fitness of the intracellular pathogen Brucella ovis within mammalian phagocytes. I initially hypothesized a host-directed mechanism of action for dihydropyridine treatment however, dose-response assays in axenic medium revealed that these drugs can directly inhibit B. ovis growth at concentrations just above that used in the screen. To explore the genetic basis of B. ovis dihydropyridine sensitivity, we selected for mutants capable of growing in the presence of the dihydropyridine cilnidipine. Cilnidipine-resistant mutants carried single-base deletions in the bepE transporter pseudogene that restored an open reading frame, enabling expression of a functional RND-family transporter. Reversion mutations that restored the bepE open reading frame increased B. ovis resistance not only to dihydropyridines but also to a broad range of cell envelope-disrupting agents. Conversely, deleting bepE in Brucella abortus, a closely related zoonotic species that retains an intact version of the gene, increased its sensitivity to envelope disruptors in vitro and to cilnidipine in the intracellular niche. As a complementary approach to small molecule screens, genetic screens can also reveal potential pharmacologic targets for host-directed therapy and inform novel pathogen biology. To this end, we conducted a genome-wide forward genetic CRISPR-Cas9 screen in THP-1 human macrophage-like cells to identify host genes that support B. ovis and B. abortus early infection. This screen revealed pan-infection host factors, and novel host cellular pathways that support Brucella infection, including the mechanistic target of rapamycin (mTOR) signaling pathway, with key genes such as LAMTOR2 and AKT1 emerging as notable hits. We validated the involvement of several candidate genes by generating targeted knockouts in THP-1 cells and through pharmacological inhibition, confirming their roles in promoting Brucella infection. These results illuminate a diverse set of host factors and cellular pathways that support infection, offering new insights into Brucella infection biology and identifying potential targets for future therapeutic intervention.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."],"dc:format":["application/pdf","1 online resource (128 p.) : ill."],"dc:identifier":["etd:52760","local:Kim_grad.msu_0128D_21743","https://doi.org/doi:10.25335/yx7g-0d25"],"dc:language":["eng"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["In Copyright"],"dc:subject":["Microbiology"],"dc:title":["Identification and characterization of intracellular Brucella inhibitors and host genes that support Brucella infection"],"dc:type":["text","Electronic dissertations"]},"updated_at":"2026-11-18T18:59:28Z"}